Precigen Inc (PGEN) Company Profile & Statistics

Precigen Inc
PGEN
(Nasdaq - US)
Closed
0.89
+0.05 (+6.45%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
0.85
High
0.93
Low
0.83

About Precigen Inc

CEO

Helen Sabzevari

Headquarters

20374 seneca meadows parkway

germantown, md 20876, united states

Auditor

Deloitte & Touche LLP

Employees

202

Share Holders

312

Website

www.precigen.com

Industry

biotechnology

Sector

health technology

Company Overview

Precigen Inc. is a biopharmaceutical company. It specialise in the development of gene and cell therapies for immuno-oncology, autoimmune disorders and infectious diseases. The company's transformative therapeutic platforms, including UltraCAR-T(TM), AdenoVerse(TM) cytokine therapies, multifunctional therapeutics and off-the-shelf AdenoVerse(TM) immunotherapies, as well as ActoBio Therapeutics, Exemplar Genetics and Triple-Gene from our subsidiaries. Precigen Inc., formerly known as Intrexon Corporation, is based in Germantown, Maryland.

Precigen Inc Statistics

Valuation Measures

Market Capitalization ²	260.86M
Enterprise Value	236.13M
Enterprise Value/EBITDA (ttm)	-1.90
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.63
Price to Sales (ttm)	58.80
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	-14.71%
Operating Margin (ttm)	-2438.03%
Profit Margin (ttm)	-3909.14%
Return on Equity (ttm)	-123.06%
Return on Invested Capital (ttm)	-231.85%
Return on Assets (ttm)	-87.33%

Income Statement

Revenue (ttm)	3.96M
Revenue Per Share (ttm)	0.01
Gross Profit (ttm)	-493.00K
EBITDA (ttm)³	-124.48M
Net Income Avi to Common (ttm)	-139.56M
Diluted EPS (ttm)	-0.55

Share Statistics

Beta (5Y Monthly)	1.68
52-Week Change	-26.39%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	292.87M
Dividend Yield	0.00%
Float ⁴	161.37M
% Held by Insiders	44.90%
% Held by Institutions	33.51%

Balance Sheet

Total Cash (mrq)	28.63M
Total Cash Per Share (mrq)	0.10
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	1.63%
Quick Ratio (mrq)	1.63%
Book Value Per Share (mrq)	0.19

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.22
Free Cash Flow (ytd)	-67.43M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Precigen Inc

Trade With A Regulated Broker